Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 14 Myelodysplastic Syndromes 6 Advanced Solid Tumors 5 Advanced Solid Tumour 4 Small Cell Lung Carcinoma 3 Recurrence 3 Myeloproliferative Disorders 3 Leukemia, Myelomonocytic, Chronic 3 Carcinoma, Non-Small-Cell Lung 3 Neoplasm Metastasis 2 Multiple Myeloma 2 Esophageal Squamous Cell Carcinoma 2 Advanced Solid Tumor 2 Advanced Breast Cancer 2 Unresectable Locally Recurrent Breast Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Non-small Lung Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1 Neuroma 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Multiple Sclerosis 1 Metastatic Solid Tumors 1 Lung Neoplasms 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Monocytic, Acute 1 Leukemia, Biphenotypic, Acute 1

Interventions

Lidocaine 1 Injections 1 Bupivacaine 1 Botulinum Toxins, Type A 1 Bevacizumab 1 Anesthetics, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroma × Injections × 30 days × Clear all

NCT07624890 2026-06-03

PRP-NEUROMA

Ukrainian Society of Regional Anesthesia and Pain Therapy

Phase NA Not yet recruiting

Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡